Nanobiotix Analyst Price Targets

Wall Street analyst price targets and consensus rating for Nanobiotix (NBTX).

Price Target Range — 5 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingOutperform# Analysts3Avg. Consensus PT$37Upside to Avg. PT+0.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 4, 2026	Leerink Partners	Jonathan Chang	PT Raise	Outperform	$37→$46
May 1, 2026	UBS	Colin Bristow	PT Raise	Neutral	$4→$30
Apr 2, 2026	Guggenheim	Michael Schmidt	PT Raise	Buy	$26→$36
Feb 6, 2026	Guggenheim	Michael Schmidt	PT Raise	Buy	$8→$26
Apr 4, 2025	Guggenheim	Michael Schmidt	PT Cut	Buy	$12→$8
Aug 28, 2024	Guggenheim	Michael Schmidt	Initiate	Buy	$12
Dec 8, 2023	Leerink Partners	Jonathan Chang	Initiate	Outperform	$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on Nanobiotix, Raises Price Target to $46

Leerink Partners analyst Jonathan Chang maintains Nanobiotix (NASDAQ:NBTX) with a Outperform and raises the price target from $37 to $46.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $26 to $36.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $8 to $26.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and lowers the price target from $12 to $8.

Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Nanobiotix with Buy Rating, Announces Price Target of $12

Guggenheim analyst Michael Schmidt initiates coverage on Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk

PRO
Leerink Partners Initiates Coverage On Nanobiotix with Outperform Rating, Announces Price Target of $11

Leerink Partners analyst Jonathan Chang initiates coverage on Nanobiotix (NASDAQ:NBTX) with a Outperform rating and announces Price Target of $11.

Benzinga Newsdesk

Nanobiotix SA

Nanobiotix Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on Nanobiotix, Raises Price Target to $46

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26

PRO
Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8

PRO
Guggenheim Initiates Coverage On Nanobiotix with Buy Rating, Announces Price Target of $12

PRO
Leerink Partners Initiates Coverage On Nanobiotix with Outperform Rating, Announces Price Target of $11

People Also Watch

People Also Watch

Nanobiotix SA

Nanobiotix Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLeerink Partners Maintains Outperform on Nanobiotix, Raises Price Target to $46

PROGuggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

PROGuggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26

PROGuggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8

PROGuggenheim Initiates Coverage On Nanobiotix with Buy Rating, Announces Price Target of $12

PROLeerink Partners Initiates Coverage On Nanobiotix with Outperform Rating, Announces Price Target of $11

People Also Watch

People Also Watch

PRO
Leerink Partners Maintains Outperform on Nanobiotix, Raises Price Target to $46

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26

PRO
Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8

PRO
Guggenheim Initiates Coverage On Nanobiotix with Buy Rating, Announces Price Target of $12

PRO
Leerink Partners Initiates Coverage On Nanobiotix with Outperform Rating, Announces Price Target of $11